Form 4: Hims & Hers Health CEO Andrew Dudum Exercises Options and Sells Shares Under 10b5-1 Plan

Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares of Class A Common Stock on October 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On October 1, 2024, Andrew Dudum, the CEO of Hims & Hers Health, Inc., exercised stock options to acquire 188,888 shares of Class A Common Stock at a price of $2.43 per share.
• Simultaneously, Dudum sold a total of 333,332 shares of Class A Common Stock in multiple transactions at weighted average prices ranging from $18.175 to $18.2174 per share.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 29, 2023.
• Following these transactions, Dudum directly owns 255,903 shares and indirectly owns millions of shares through various trusts.
• The indirect holdings are managed by trustees of several trusts, including the Andrew Dudum 2015 Trust, AD 2022 GRATs, AD 2021 GRATs, the Dudum Family Community Property Trust, the AD 2023 GRAT, the Richard M. Dudum Irrevocable 1 U/A dtd 10/15/1997, and the Dudum Family Heritage Trust UAD 8-10-2021.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, as it's a factual report of stock option exercises and sales.

Industry Context

This filing is a routine disclosure of insider transactions and is common for publicly traded companies. The use of a 10b5-1 plan allows insiders to sell shares without being accused of acting on non-public information.

Comparison to Industry Standards

• The use of Rule 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the healthcare and technology sectors.
• Companies like Teladoc Health and GoodRx, which operate in similar telehealth spaces, also see regular Form 4 filings from their executives.
• The reported prices and volumes are within typical ranges for insider transactions at companies of Hims & Hers Health's size and market capitalization.

Stakeholder Impact

• The transactions could have a minor impact on shareholders due to the increased supply of shares in the market.
• However, the pre-planned nature of the sales under the 10b5-1 plan mitigates concerns about insider information influencing the transactions.

Key Dates